A detailed history of Cibc Private Wealth Group, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 3,845 shares of ADPT stock, worth $18,033. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,845
Previous 5,050 23.86%
Holding current value
$18,033
Previous $18,000 5.56%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$3.37 - $5.12 $4,060 - $6,169
-1,205 Reduced 23.86%
3,845 $19,000
Q1 2024

May 10, 2024

BUY
$2.88 - $4.8 $14,544 - $24,240
5,050 New
5,050 $16,000
Q3 2022

Nov 14, 2022

BUY
$6.5 - $12.67 $7,117 - $13,873
1,095 Added 8.86%
13,460 $96,000
Q2 2022

Aug 03, 2022

BUY
$6.4 - $14.73 $2,048 - $4,713
320 Added 2.66%
12,365 $100,000
Q1 2022

May 16, 2022

BUY
$10.12 - $28.9 $11,536 - $32,946
1,140 Added 10.45%
12,045 $167,000
Q4 2021

Feb 08, 2022

SELL
$25.17 - $36.85 $22,527 - $32,980
-895 Reduced 7.58%
10,905 $306,000
Q3 2021

Nov 12, 2021

BUY
$30.02 - $39.87 $30,020 - $39,870
1,000 Added 9.26%
11,800 $401,000
Q2 2021

Aug 16, 2021

BUY
$32.22 - $44.59 $28,998 - $40,131
900 Added 9.09%
10,800 $441,000
Q1 2021

May 12, 2021

BUY
$37.26 - $67.74 $1,863 - $3,386
50 Added 0.51%
9,900 $399,000
Q3 2020

Nov 03, 2020

BUY
$35.79 - $48.81 $352,531 - $480,778
9,850 New
9,850 $479,000
Q2 2020

Aug 13, 2020

SELL
$24.95 - $48.38 $314,370 - $609,588
-12,600 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$16.96 - $34.16 $18,656 - $37,575
1,100 Added 9.57%
12,600 $350,000
Q4 2019

Jan 30, 2020

BUY
$24.56 - $32.8 $28,244 - $37,720
1,150 Added 11.11%
11,500 $344,000
Q3 2019

Oct 16, 2019

BUY
$30.31 - $53.51 $313,708 - $553,828
10,350 New
10,350 $320,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $670M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.